Impact of age and histological type on programmed death-ligand 1 expression in non-small cell lung cancer - a single-center analysis of 1,606 cases
{{output}}
Programmed death-ligand 1 (PD-L1) guides immune checkpoint inhibitor use in non-small cell lung cancer (NSCLC), yet its variation by age and histology remains uncertain. We retrospectively evaluated 1,606 consecutive NSCLC cases (2017-2022) with PD-L1 immunohi... ...
